CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$27,000
-15.6%
127,6390.0%0.00%
Q2 2022$32,000
+14.3%
127,639
+162.8%
0.00%
Q4 2021$28,000
-44.0%
48,5600.0%0.00%
Q3 2021$50,000
-26.5%
48,5600.0%0.00%
Q2 2021$68,000
-84.8%
48,560
-81.5%
0.00%
Q1 2021$446,000
+77.0%
262,199
+29.5%
0.00%
Q4 2020$252,000
-5.6%
202,469
+8.0%
0.00%
Q3 2020$267,000
+7.2%
187,409
-8.9%
0.00%
Q2 2020$249,000
+10.2%
205,616
+7.4%
0.00%
Q1 2020$226,000
-44.2%
191,4830.0%0.00%
Q4 2019$405,000
-4.0%
191,4830.0%0.00%
Q3 2019$422,000
-13.0%
191,4830.0%0.00%
Q2 2019$485,000
+389.9%
191,483
+573.3%
0.00%
Q1 2019$99,000
+191.2%
28,438
+93.5%
0.00%
Q4 2018$34,000
-40.4%
14,7000.0%0.00%
Q3 2018$57,000
-68.5%
14,700
-74.3%
0.00%
Q1 2017$181,000
+21.5%
57,3000.0%0.00%
Q4 2016$149,000
-33.2%
57,3000.0%0.00%
Q3 2016$223,000
+43.9%
57,3000.0%0.00%
Q2 2016$155,000
-0.6%
57,300
+42.5%
0.00%
Q1 2015$156,000
-42.4%
40,2000.0%0.00%
Q4 2014$271,000
+22.6%
40,2000.0%0.00%
Q3 2014$221,000
-46.5%
40,2000.0%0.00%
-100.0%
Q2 2014$413,000
-14.5%
40,2000.0%0.00%0.0%
Q1 2014$483,000
+42.9%
40,200
+34.9%
0.00%0.0%
Q4 2013$338,000
+2.1%
29,8000.0%0.00%0.0%
Q3 2013$331,000
+12.6%
29,8000.0%0.00%0.0%
Q2 2013$294,00029,8000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 3,731,342$8,022,0000.40%
WealthTrust Axiom LLC 210,000$451,0000.17%
Palo Alto Investors LP 1,032,715$2,220,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 144,536$311,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$107,0000.06%
Joel Isaacson & Co., LLC 70,660$152,0000.03%
LMR Partners LLP 148,309$319,0000.02%
LINCOLN CAPITAL CORP 10,000$22,0000.02%
Malaga Cove Capital, LLC 13,150$28,0000.02%
Cornerstone Capital, Inc. 30,000$65,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders